Abiopharma

New Form 6-K - EDAP TMS SA Filed: 2025-08-26 AccNo: 0001171843-25-005588 Size: 14 KB

Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis

General Announcement: Announcement by TMC Life Sciences Berhad - 4Q2025 and FY2025 audited results

Marker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma

Syndax Announces Participation in September Investor Conferences

Voyager to Present at Upcoming Investor Conferences

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

Sagimet Biosciences to Participate in Two Upcoming Investor Conferences

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

EyePoint Announces Participation at Upcoming Investor Conferences

Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference

Unicycive Therapeutics to Participate in Upcoming Investor Events in September

Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Perspective Therapeutics to Participate in Upcoming September Conferences